Topics
Pediatric-type diffuse high-grade gliomas | Treatment | Clinical trials | Dabrafenib
Home > Publications > Topics > Pediatric-type diffuse high-grade gliomas > Treatment > Clinical trials > Dabrafenib
Geoerger B, Moreno L, Bouffet E, Upadhyaya SA, André N,
Aerts I, Plant-Fox AS, Roughton M, Russo M, Hargrave D.
Dabrafenib in pediatric patients with
BRAF
V600 mutation-positive high-grade glioma: Results from a phase
1/2a single-arm study.
Neurooncol
Pract. 2025 Aug 16;12(6):1099-1111. doi:
10.1093/nop/npaf061. PMID:
41458923. Interventional study. ˍ